Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 17, 2026
Why Is AirSculpt Technologies (AIRS) Stock Down -11.37% Today?

Why Is AirSculpt Technologies (AIRS) Stock Down -11.37% Today?

Key Takeaways

  • Shares of AIRS fell 11.37% to $3.04 in Monday trading, down $0.39 from Friday’s close of $3.43.
  • The decline extends post-earnings turbulence following the company’s August 10 second-quarter report.
  • Q2 revenue of $42.9 million missed consensus and fell 3% year over year; the full-year adjusted EBITDA outlook was cut to $12–$14 million.
  • No fresh company-specific announcement was apparent during Monday’s slide, pointing to technical and sentiment-driven selling.
  • Traders are watching the $3.00 area and upcoming Q3 case-volume and margin trends.

Opening Summary

AirSculpt Technologies, Inc. (AIRS) is a provider of minimally invasive body contouring procedures in the United States and Canada. In Monday afternoon trading, shares dropped 11.37% to $3.04, compared with Friday’s close of $3.43. The decline extended a period of elevated volatility that began when the company reported second-quarter results on August 10, and the market’s immediate focus remained on the weaker profitability outlook rather than on any new corporate announcement.

Q2 Results and Lowered Profit Outlook

The primary overhang on AIRS remains the second-quarter report released before the market open on August 10. Revenue came in at $42.9 million, down 3% from $44.0 million a year earlier and below the consensus estimate of roughly $44.2 million. Net loss widened to $1.1 million from $0.6 million in the prior-year period, while adjusted EBITDA declined to $4.9 million from $5.8 million.

Management reaffirmed full-year revenue guidance but said results are expected to track toward the lower end of the $151 million-to-$157 million range. More importantly for investor sentiment, the company reduced its full-year adjusted EBITDA guidance to $12 million-to-$14 million. That downward revision to profitability expectations has kept selling pressure on the stock even after the initial post-earnings reaction.

Technical Selling and Post-Earnings Volatility

The stock’s recent path illustrates how volatile AIRS has become. The shares closed at $5.01 on August 7, then collapsed to $2.75 on August 10 after the earnings release. A partial recovery followed over the next four sessions, lifting the stock back to $3.43 by August 14. Monday’s slide to $3.04 unwound most of that rebound in a single session.

With a beta near 2.4 and a relatively small float, AIRS is prone to outsized intraday moves. The absence of a fresh company-specific catalyst during Monday’s decline suggests that the move was driven by continued digestion of the lowered earnings outlook, profit-taking after last week’s bounce, and momentum-driven selling once the shares surrendered key short-term support.

Market Context and Trading Activity

Turnover in AIRS has been elevated relative to early-August levels since the earnings report. Daily volume surged to roughly 2.5 million shares on August 10 and remained well above the early-August baseline in subsequent sessions, reflecting intense two-way trading as investors repositioned.

The selling on Monday appeared largely company-specific rather than tied to a broad market catalyst. The stock’s slide below the $3.30 level and toward $3.00 placed it back near the lower end of its recent post-earnings range, a technical breakdown that likely contributed to additional selling pressure during the afternoon.

What Comes Next for AIRS

Investors will be watching whether AIRS can stabilize above the $3.00 level or whether the post-earnings range continues to compress. The next scheduled quarterly report is expected in November, and management commentary on same-center case volumes, revenue per case, and adjusted EBITDA margins will be central to the investment debate.

Additional focus areas include the rollout of newer procedures such as skin tightening and skin removal, the planned AlloClae pilot, demand trends among GLP-1 patients, and progress on debt refinancing. Consumer spending on elective cosmetic procedures remains a key macroeconomic risk, and the company’s ability to convert higher marketing investment into sustained case growth will likely determine whether the recent volatility gives way to a more durable trend.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing traders to explore automated approaches tailored to different market environments. Investors seeking a data-driven way to monitor opportunities across active tickers may find the section a useful starting point.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AIRS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AIRS's Indicator enters downward trend

The Aroon Indicator for AIRS entered a downward trend on September 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 240 similar instances where the Aroon Indicator formed such a pattern. In 223 of the 240 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AIRS as a result. In 63 of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AIRS's RSI Oscillator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for AIRS just turned positive on September 03, 2026. Looking at past instances where AIRS's MACD turned positive, the stock continued to rise in 34 of 42 cases over the following month. The odds of a continued upward trend are 81%.

Following a +9.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where AIRS advanced for three days, in 230 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

AIRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. AIRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.589) is normal, around the industry mean (208.357). P/E Ratio (196.563) is within average values for comparable stocks, (175.235). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.492). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.921) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 4.85B. The market cap for tickers in the group ranges from 20.9K to 92.6B. HCA holds the highest valuation in this group at 92.6B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -4%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 37%. WW experienced the highest price growth at 8%, while BMGL experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 175%. For the same stocks of the Industry, the average monthly volume growth was 144% and the average quarterly volume growth was 26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 45
Price Growth Rating: 51
SMR Rating: 66
Profit Risk Rating: 87
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
AIRS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Details
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 786 709-9690
Employees
453
Web
https://www.airsculpt.com
Interact to see
Advertisement
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.
NG shares fell over 11% today, giving back a portion of steep gains that had taken the stock from near US$2.30 a year ago to recent highs around US$14.40 before the latest pullback. The decline follows a cluster of Donlin‑related announcements — including selection of Fluor as Bankable Feasibility Study (BFS) contractor and an infrastructure/energy letter of intent — which, while positive, highlighted the scale, cost and timeline of the project rather than near‑term cash generation.
SA dropped over 9% today, sliding from around US$30–31 toward the high‑US$27 range in morning trading, as recent optimism about a near‑term KSM partnership met renewed focus on execution and valuation risk. Recent analysis has highlighted that Seabridge’s 2026 “report card” allocates 55% of management’s performance weighting to KSM‑related goals, with securing a JV partner given the single largest weight at 30%, underscoring how concentrated the investment thesis has become.
CABO shares fell over 11% today, sliding from the low‑US$110s toward the US$100 area, extending a brutal 12‑month decline of roughly 55% and bringing the stock closer to the bottom of its 52‑week range near US$70. Q4 2025 results showed a 6.1% year‑over‑year revenue drop to US$363.7 million, with residential data revenue down 4.2% and business data off 1.3%; full‑year revenue fell to about US$1.5 billion from US$1.6 billion in 2024.
In a market rattled by geopolitical tension, tariff uncertainty, and Fed rate volatility, one category of stocks continues to electrify traders: penny stocks, microcaps, and small-caps. These sub-$5 shares can surge 50%, 100%, or even 150% in a single session on a news catalyst — but without the right tools, most retail traders get caught on the wrong side. Enter Tickeron's two powerhouse AI robots: the Small-Cap Stocks - AI Trend Trader 60min (FA) and the Penny Stock - MicroCap Signal Bot 60min (FA).
Elite Returns in a Volatile Sector — Both robots delivered annualized returns above 94%, outperforming the vast majority of active semiconductor funds. High Consistency — Win rates of 68–71% mean these robots win more often than they lose — a rare edge in a sector famous for violent swings.
Exceptional Returns: +79.13% annualized return on a starting balance of $8,040.74, demonstrating consistent alpha generation in the comms-tech sector. High Win Rate: 59.43% of trades close in profit, with a Profit Factor of 2.65 — meaning every $1 risked historically returns $2.65.
Tight Risk Management — The 3% TP / 2% SL corridor keeps risk-reward structured and disciplined, cutting losses quickly while locking in gains before reversals. Right Tickers, Right Time — XOM, CVX, and COP are all up roughly 30% year-to-date in 2026, making them among the most high-momentum, liquid energy plays in the market right now.
AngloGold Ashanti (AU) shares are tumbling approximately 11% in premarket trading on March 19, 2026, extending a steep multi-week correction that has now erased more than 35% of the stock's value from its March 2 peak of $129.14. The primary sustained catalyst driving the decline is AngloGold's lowered 2026 production guidance, projecting gold output of 2.80–3.17 million ounces — a mid-point decline versus the company's 2025 output of approximately 3.1 million ounces, and below analyst expectations.
CSIQ shares tumbled approximately 18% in premarket trading on March 19, 2026, following the release of deeply disappointing Q4 2025 earnings before the open. The company reported a net loss of $1.66 per diluted share, far worse than the Wall Street consensus estimate of -$0.98, representing a 69% earnings miss.
YRD shares are tumbling approximately 17% in premarket trading on March 19, 2026, from a prior close of $3.68 to approximately $3.05, following the company's release of Q4 and full-year 2025 financial results before the U.S. market open. Primary catalyst: A dramatic swing to net loss in Q4 2025. Yiren Digital reported a Q4 net loss of RMB 882.2 million (~USD 126.1 million), compared to net income of RMB 331.4 million in Q4 2024 — a more than $250 million deterioration year-over-year.
Shares of MU are down approximately 6.66% in premarket trading on March 19, 2026, sliding from a prior close of $461.73 to around $431.00. Despite a historic earnings beat — fiscal Q2 2026 revenue of $23.86 billion versus the $19.19 billion consensus, and adjusted EPS of $12.20 against an $8.79 estimate — the stock is experiencing a classic "sell the news" reaction.